Patients with truncal obesity but with no evidence of hypopituitarism have relative GH deficiency, and it is exciting that low-dose GH treatment in this group, by inhibiting cortisol generation within omental fat, may offer an effective therapeutic approach (43). This evidence concerns the gene GH1 and Truncal obesity.